Medica policy

Stem Cell and Cellular Bone Matrix Products for Orthopedic Applications

Stem Cell and Cellular Bone Matrix Products for Orthopedic Applications is a public Medica policy (effective Sep 1, 2026). It lists 7 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.

View the original policy (PDF) ↗

Payer: Medica
Effective: Sep 1, 2026
Line of business: Commercial, Medicaid
Source: partner.medica.com

Codes in this policy

The CPT and HCPCS codes the policy names. A policy can name a code it excludes.

Code	Other Medica policies
0565T	Policies naming 0565T
0566T	Policies naming 0566T
0627T	Policies naming 0627T
0628T	Policies naming 0628T
0629T	Policies naming 0629T
0630T	Policies naming 0630T
20939	Policies naming 20939

All Medica policies

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.